MANE Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026
Revenue
0
0
0
Cost of Revenue
0
0
0
Gross Profit
0
0
0
Operating Expenses
28.8M
-2.6%
29.6M
-1.0%
29.9M
R&D
16.1M
-13.6%
18.6M
-11.1%
20.9M
SG&A
12.7M
+16.1%
10.9M
+22.5%
8.9M
Operating Income
-28779000
+2.6%
-29553000
+1.0%
-29862000
EBITDA
-28779000
+2.6%
-29553000
+1.0%
-29862000
Net Income
-20999000
+10.7%
-23502000
+13.7%
-27232000
EPS (Basic)
$-0.50
+13.8%
$-0.58
+56.1%
$-1.32
EPS (Diluted)
$-0.50
+13.8%
$-0.58
+56.1%
$-1.32
Shares (Diluted)
42.1M
+4.2%
40.4M
+78.1%
22.7M
Veradermics (MANE) — Financials